Anatomage will focus on its medical and educational solutions. The move will allow each company to focus on expanded innovation in its core specialty. Anatomage founder and CEO Jack Choi will continue to serve Osteoid as an advisor. Calvin Hur, an over 20-year veteran of the 3D design and printing industry, will lead Osteoid as its CEO, where he will oversee strategic direction and product roadmap. 25, 2021 (GLOBE NEWSWIRE) - Anatomage, a market leader in medical visualization technology, announced that the company has spun out its 3D dental business as a wholly owned subsidiary called Osteoid. Connected approach add precision and efficiency to help dentists, labs, and partners accelerate the move to digital technology.Extensive R&D, new product development in Invivo 3D dental software, Invivo Workspace cloud-based solution, surgical planning guides and imaging products.Osteoid taps industry veteran Calvin Hur as CEO.Company separates medical and dental business units, bringing greater focus to each.A wholly owned subsidiary, Osteoid to focus on its award-winning Invivo solutions and add new capabilities to power the future of digital dentistry CEO Jack Choi remains an advisor
